EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer

Monika Kuzma, Lucie Nekvindova, Jan Kliment

Bratislava Medical Journal · 2024

DOI: 10.4149/bll_2024_89 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Monika Kuzma und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Quality of Life, Prostatic Neoplasms, Castration-Resistant, Benzamides, Phenylthiohydantoin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeProstatic Neoplasms, Castration-ResistantBenzamidesPhenylthiohydantoinNitrilesHumansMaleAgedProspective StudiesMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsAndrostenesPrednisoneAged, 80 and overAbiraterone AcetateReceptors, Androgen

Substanzen

BenzamidesenzalutamidePhenylthiohydantoinNitrilesAndrostenesPrednisoneabirateroneAbiraterone AcetateReceptors, Androgen

Zitieren

APA

Kuzma, M., Nekvindova, L., & Kliment, J. (2024). Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_89

Vancouver

Kuzma M, Nekvindova L, Kliment J. Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer. Bratislava Medical Journal. 2024. doi:10.4149/bll_2024_89

BibTeX
@article{Kuzma2024,
  author = {Kuzma, Monika and Nekvindova, Lucie and Kliment, Jan},
  title = {Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer},
  journal = {Bratislava Medical Journal},
  year = {2024},
  doi = {10.4149/bll_2024_89}
}
Kostenlos starten →